Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and EfficacY of CombinatioN Belimumab and Voclosporin in the TrEatment of PRoliferative Forms of Lupus Glomerulopathy: Synergy Trial

NCT07225387 is registered in ClinicalTrials.gov with NephroNet, Inc. as lead sponsor.

NCT NCT07225387
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07225387 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and EfficacY of CombinatioN Belimumab and Voclosporin in the TrEatment of PRoliferative Forms of Lupus Glomerulopathy: Synergy Trial
Lead sponsor
NephroNet, Inc.
Phase
Phase 4
Overall status
Recruiting
Start date
October 1, 2024
Completion date
January 31, 2027
Enrollment
30 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

lupus nephritis